Asymmetric Dimethylarginine and Adiponectin After Renal Transplantation: Role of Obesity

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 154-157

  Teplan, Vladimir ^a   Schück, Otto ^a   Racek, Jaroslav ^b   Siroka, Romana ^b   Haluzik, Martin ^b   Kudla, Michal ^a   Vitko, Stefan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ARGININE; DIMETHYLARGININE; DRUG DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; COHORT ANALYSIS; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ADIPONECTIN; ADULT; AGED; ARGININE; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES;

EID: 37049017343     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.030     Document Type: Article

References (25)

1. Gore J.L., Pham P.T., Danovitch M., et al. Obesity and outcome following renal transplantation. Am J Transplant 6 (2006) 357-363
2. Cofán F., Vela E., Cléries M., et al. Obesity in renal transplantation: analysis of 2694 patients. Transplant Proc 37 (2005) 3695-3697
3. Jindal R.M., and Zawada Jr. E.T. Obesity and kidney transplantation. Am J Kidney Dis 43 (2004) 943-952
4. Meier-Kriesche H.V., Arndorfer J.A., and Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73 (2002) 70-74
5. Armstrong K.A., Campbell S.B., Hawley C.H., et al. Impact of obesity on renal transplant outcomes. Nephrology 10 (2005) 405-413
6. Boots J.M., Christiaens M.H., and van Hoof J.P. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs 64 (2004) 2047-2073
7. Kasap B., Soylu A., Türkmen M., Karakcu S., Bora S., and Gülay H. Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients. Transplant Proc 38 (2006) 463-465
8. Teplan V., Schück O., Štollová M., and Vítko S. Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant 18 Suppl 5 (2003) v71-v73
9. Vallance P., Leone A., Calver A., Colier J., and Moncada S. Accumulation of endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
10. Boger R.H. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 41 (2003) 1467-1472
11. Kielstein J.T., Frölich J.C., Haller H., and Fliser D. ADMA: An atherosclerotic disease mediating agent in patients with renal disease?. Nephrol Dial Transplant 16 (2001) 1742-1745
12. Kielstein J.T., Boger R.H., Bode-Boger S.M., et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13 (2002) 170-176
13. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
14. Yilmaz M.I., Saglam M., Caglar K., et al. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80 (2005) 1660-1666
15. El-Agroudy A.E., Wafa E.W., Gheit O.E., et al. Weight gain after renal transplantation is a risk factor for patients and graft outcome. Transplantation 77 (2004) 1381-1385
16. Johnson D.W., Isbel N.M., Brown A.M., et al. The effect of obesity on renal transplant outcomes. Transplantation 74 (2002) 675-681
17. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with and stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
18. Stenvienkel P., Marchlewska A., Pecoits-Filho R., et al. Adiponectin in renal disease: relationship to phenotype and genetic variation of the gene encoding adiponectin. Kidney Int 65 (2003) 274-281
19. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
20. Haluzik M., Parizkova J., and Haluzik M.M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53 (2004) 123-129
21. Havel P.J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein and adiponectin. Curr Opin Lipidol 13 (2002) 51-59
22. Chudek J., Adamczak M., Karkoszka H., et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 35 (2003) 2186-2189
23. Fliser D., Kronenberg F., Kielstein J.T., et al. Asymmetric dimethylarginine and progression of chronic kidney disease: the Mild and Moderate Kidney Disease Study. J Am Soc Nephrol 16 (2005) 2456-2461
24. Sciaqua A., Candigliota M., Ceravolo R., et al. Weight loss in combination in human obesity. Diabetes Care 26 (2003) 1673-1678
25. Oflaz H., Turkmen A., Kazancioglu R., et al. The effects of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 17 (2003) 212-216